Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06255054 · ClinicalTrials.gov registry record
Novel Approaches to Assessing Cannabis Impaired Driving (NAACID)
A clinical trial, sponsored by Colorado School of Public Health.
- Completed
- Registry status
- 207
- Enrollment target
NCT06255054: Completed study, sponsored by Colorado School of Public Health.
NCT06255054 is a clinical trial that has completed, run by Colorado School of Public Health. The registered enrollment target is 207 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06255054 has completed, sponsored by Colorado School of Public Health.
- COMPLETED
- Registry status
- 207 participants
- Enrollment target
Study Summary
Researchers at the University of Colorado Anschutz Medical Campus, Colorado School of Public Health, and Injury \& Violence Prevention Center want to learn more about how people are affected by cannabis in different ways. The study will use a driving simulator to compare the driving performance of adults who use cannabis daily, occasionally or have not recently used cannabis.
Primary Outcome
SDLP (standard deviation of lateral position) is measured by our Advanced NADS minisim
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 207 participants |
| Start Date | 2020-06-20 |
| Est. Completion | 2024-09-14 |
What the finished NCT06255054 record still lists
NCT06255054 is an observational study that tracks outcomes without assigning an intervention. The registered 207 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT06255054 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06255054 about?
NCT06255054 is a clinical study titled "Novel Approaches to Assessing Cannabis Impaired Driving (NAACID)". Researchers at the University of Colorado Anschutz Medical Campus, Colorado School of Public Health, and Injury \& Violence Prevention Center want to learn more about how people are affected by cannabis in different ways. The study will use a driving simulator to compare the driving performance of a...
What is the current status of trial NCT06255054?
This trial is currently completed. The enrollment target is 207 participants. The study started on 2020-06-20. Estimated completion is 2024-09-14.
Who is sponsoring clinical trial NCT06255054?
This trial is sponsored by Colorado School of Public Health, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04353778 · 207 participants · Phase 1
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
- NCT05875805 · 207 participants · NA
A Telehealth Advance Care Planning Intervention
- NCT06254950 · 207 participants · Phase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
- NCT06904274 · 207 participants · Phase 3
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI